Announcements Trials
Browse Landscape

Status

Completed 7Recruiting 3Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 20Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 566Neoplasms 463Lung Neoplasms 295Colorectal Neoplasms 291Carcinoma, Non-Small-Cell Lung 213Stomach Neoplasms 209Carcinoma, Hepatocellular 201Prostatic Neoplasms 181Pancreatic Neoplasms 151Ovarian Neoplasms 138Uterine Cervical Neoplasms 126Colonic Neoplasms 121Rectal Neoplasms 113Urinary Bladder Neoplasms 96Neoplasm Metastasis 95Esophageal Neoplasms 85Endometrial Neoplasms 83Head and Neck Neoplasms 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Myeloid, Acute 78Recurrence 68Brain Neoplasms 68Melanoma 66Disease 64Multiple Myeloma 59Liver Neoplasms 58Lymphoma 57Glioma 56Polycystic Ovary Syndrome 53Squamous Cell Carcinoma of Head and Neck 51

Interventions

Platelet Aggregation 1Bleeding Time 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Observational × Unspecified Adult Solid Tumor, Protocol Specific × Clear all
NCT00898794 2013-08-07

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

National Cancer Institute (NCI)

Unknown
20 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡